| Bradley Home & Pavillion, The | |
| 320 Colony Street, Meriden, Connecticut 06450 | |
| (203) 235-5716 | |
| Name | Bradley Home & Pavillion, The |
|---|---|
| Location | 320 Colony Street, Meriden, Connecticut |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 30 |
| Occupancy Rate | 87% |
| Medicare ID (CCN) | 075439 |
| Legal Business Name | The Bradley Home |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1447357611 |
| Organization Name | THE BRADLEY HOME |
| Address | 320 Colony St, Meriden, CT 06451 |
| Phone Number | 203-235-5716 |
News Archive
Long-term use of a calcium-channel blocker to treat hypertension (high blood pressure) is associated with higher breast cancer risk, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that study results demonstrated that arimoclomol exhibited both statistically significant neuroprotective and neuroregenerative effects in brain cells of animals induced with stroke, offering important insights into this drug candidate's mechanism of action.
Washington Post columnist Michael Gerson writes of the "breathless Associated Press story" about the uncovering of some corruption in grants given by the Global Fund to Fight AIDS, Tuberculosis and Malaria and the subsequent reaction: "When scandals fit preexisting ideological narratives, they assume a life of their own. This particular narrative - the story of useless, wasted aid - is durable. It is also misleading and might be deadly."
When expressed (turned on), the gene (hTERT) located on Chromosome number 5p15.33 activates the enzyme telomerase. Human cells can keep living and dividing indefinitely when telomerase is continually present; i.e. the cells become immortal. Telomerase Activation Sciences, Inc. (T.A. Sciences®) announces TA-65® can extend human cell life indefinitely. TA-65® is a single molecule telomerase activator that turns on the Immortality Gene under controlled laboratory conditions.
Heart transplant recipients and their physicians are likely more concerned with the function of the donated organ than with the donor's DNA sequences that tag along in the new, healthy tissue.
› Verified 6 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Long-term use of a calcium-channel blocker to treat hypertension (high blood pressure) is associated with higher breast cancer risk, according to a report published by JAMA Internal Medicine, a JAMA Network publication.
CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company engaged in the development of high-value human therapeutics, today announced that study results demonstrated that arimoclomol exhibited both statistically significant neuroprotective and neuroregenerative effects in brain cells of animals induced with stroke, offering important insights into this drug candidate's mechanism of action.
Washington Post columnist Michael Gerson writes of the "breathless Associated Press story" about the uncovering of some corruption in grants given by the Global Fund to Fight AIDS, Tuberculosis and Malaria and the subsequent reaction: "When scandals fit preexisting ideological narratives, they assume a life of their own. This particular narrative - the story of useless, wasted aid - is durable. It is also misleading and might be deadly."
When expressed (turned on), the gene (hTERT) located on Chromosome number 5p15.33 activates the enzyme telomerase. Human cells can keep living and dividing indefinitely when telomerase is continually present; i.e. the cells become immortal. Telomerase Activation Sciences, Inc. (T.A. Sciences®) announces TA-65® can extend human cell life indefinitely. TA-65® is a single molecule telomerase activator that turns on the Immortality Gene under controlled laboratory conditions.
Heart transplant recipients and their physicians are likely more concerned with the function of the donated organ than with the donor's DNA sequences that tag along in the new, healthy tissue.
› Verified 6 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 29.13 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 12.36 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 63.27 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.35 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.9 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.1 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 13.33 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 82.61 | 83.88 |